

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.60132536 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.42007321 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.07001209 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.06284669 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.76365971 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.76365971 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.91787163 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.37164085 |
| 9 | negative T cell selection (GO:0043383) | 4.33062363 |
| 10 | positive thymic T cell selection (GO:0045059) | 4.24181375 |
| 11 | cytidine metabolic process (GO:0046087) | 4.18559970 |
| 12 | cytidine catabolic process (GO:0006216) | 4.18559970 |
| 13 | cytidine deamination (GO:0009972) | 4.18559970 |
| 14 | negative thymic T cell selection (GO:0045060) | 4.12607223 |
| 15 | type I interferon signaling pathway (GO:0060337) | 4.02396251 |
| 16 | cellular response to type I interferon (GO:0071357) | 4.02396251 |
| 17 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.00892181 |
| 18 | regulation of regulatory T cell differentiation (GO:0045589) | 4.00663458 |
| 19 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.00583291 |
| 20 | response to type I interferon (GO:0034340) | 3.99239234 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.97636753 |
| 22 | positive T cell selection (GO:0043368) | 3.93516979 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.91386685 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 3.89345410 |
| 25 | leukocyte aggregation (GO:0070486) | 3.83801105 |
| 26 | response to interferon-beta (GO:0035456) | 3.80929792 |
| 27 | T cell migration (GO:0072678) | 3.79975719 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 3.74789072 |
| 29 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.74590941 |
| 30 | regulation of T cell tolerance induction (GO:0002664) | 3.73421823 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 3.73371710 |
| 32 | positive regulation of tolerance induction (GO:0002645) | 3.71830407 |
| 33 | regulation of tolerance induction (GO:0002643) | 3.67429850 |
| 34 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.64681423 |
| 35 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.64681423 |
| 36 | thymic T cell selection (GO:0045061) | 3.63933147 |
| 37 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.62858460 |
| 38 | detection of bacterium (GO:0016045) | 3.61746930 |
| 39 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.60360724 |
| 40 | response to interleukin-15 (GO:0070672) | 3.56570324 |
| 41 | T cell selection (GO:0045058) | 3.54111038 |
| 42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.53156971 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.47858015 |
| 44 | detection of other organism (GO:0098543) | 3.46894441 |
| 45 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.43451160 |
| 46 | tolerance induction (GO:0002507) | 3.39878563 |
| 47 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.37788427 |
| 48 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.30187683 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.29388021 |
| 50 | regulation of cellular extravasation (GO:0002691) | 3.29203746 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.28673374 |
| 52 | regulation of cell killing (GO:0031341) | 3.26253218 |
| 53 | positive regulation of cell killing (GO:0031343) | 3.24878084 |
| 54 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.17017029 |
| 55 | neutrophil activation involved in immune response (GO:0002283) | 3.16845303 |
| 56 | NIK/NF-kappaB signaling (GO:0038061) | 3.14552989 |
| 57 | B cell mediated immunity (GO:0019724) | 3.14400777 |
| 58 | regulation of antigen processing and presentation (GO:0002577) | 3.12092024 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10448013 |
| 60 | T cell receptor signaling pathway (GO:0050852) | 3.09078565 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.08013015 |
| 62 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.05835608 |
| 63 | T cell costimulation (GO:0031295) | 3.05038942 |
| 64 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.04879915 |
| 65 | lymphocyte costimulation (GO:0031294) | 3.02603448 |
| 66 | negative regulation of viral genome replication (GO:0045071) | 3.01172865 |
| 67 | dendritic cell chemotaxis (GO:0002407) | 2.99227378 |
| 68 | positive regulation of B cell differentiation (GO:0045579) | 2.98284438 |
| 69 | lymphocyte chemotaxis (GO:0048247) | 2.93348771 |
| 70 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.91958682 |
| 71 | actin nucleation (GO:0045010) | 2.88945684 |
| 72 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.87483033 |
| 73 | negative regulation of innate immune response (GO:0045824) | 2.86787935 |
| 74 | negative regulation of T cell mediated immunity (GO:0002710) | 2.85815102 |
| 75 | positive regulation of T cell mediated immunity (GO:0002711) | 2.83813803 |
| 76 | regulation of T cell mediated immunity (GO:0002709) | 2.83375702 |
| 77 | regulation of B cell differentiation (GO:0045577) | 2.81272135 |
| 78 | cellular response to interferon-beta (GO:0035458) | 2.81005733 |
| 79 | lymphocyte migration (GO:0072676) | 2.80521769 |
| 80 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.77179341 |
| 81 | cellular response to interferon-gamma (GO:0071346) | 2.76360561 |
| 82 | DNA deamination (GO:0045006) | 2.76264297 |
| 83 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.75846120 |
| 84 | neutrophil activation (GO:0042119) | 2.75036554 |
| 85 | activated T cell proliferation (GO:0050798) | 2.70737041 |
| 86 | dendritic cell migration (GO:0036336) | 2.67867833 |
| 87 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.67528153 |
| 88 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.66642092 |
| 89 | cellular defense response (GO:0006968) | 2.66069127 |
| 90 | response to interferon-gamma (GO:0034341) | 2.65213799 |
| 91 | detection of external biotic stimulus (GO:0098581) | 2.64000914 |
| 92 | negative regulation of T cell apoptotic process (GO:0070233) | 2.62112205 |
| 93 | positive regulation of defense response to virus by host (GO:0002230) | 2.61779702 |
| 94 | mast cell activation (GO:0045576) | 2.61446266 |
| 95 | macrophage activation involved in immune response (GO:0002281) | 2.59062598 |
| 96 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.58480318 |
| 97 | chemokine-mediated signaling pathway (GO:0070098) | 2.58212865 |
| 98 | negative regulation of interleukin-12 production (GO:0032695) | 2.58162583 |
| 99 | B cell receptor signaling pathway (GO:0050853) | 2.57826014 |
| 100 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.57703481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.66832969 |
| 2 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.20353512 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.30137818 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.26841589 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.74908188 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.62639638 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.17183194 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.85458895 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 2.63267237 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.55833063 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.52364533 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50978952 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.46425597 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46270169 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35067197 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.20787016 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20572251 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13081281 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.09087860 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.01992185 |
| 21 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.00662737 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.97283119 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90861163 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.84950349 |
| 25 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.84624470 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84059480 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82924240 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72880915 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.71197109 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68028930 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67431553 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63289666 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60365925 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59312663 |
| 35 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59167018 |
| 36 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.58240082 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.51270174 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50253663 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49807671 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48742830 |
| 41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.47270981 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46649472 |
| 43 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.43315952 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35464222 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33928385 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31095535 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29521451 |
| 48 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25834503 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24313707 |
| 50 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22583315 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18801629 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16262140 |
| 53 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15778104 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15380257 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14759581 |
| 56 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.14278059 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12949189 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12810604 |
| 59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12695803 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12410178 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12141463 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11191888 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09992111 |
| 64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05768182 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04519734 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03792423 |
| 67 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02765215 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02479406 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01738195 |
| 70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00724774 |
| 71 | * P300_27268052_Chip-Seq_Bcells_Human | 0.99937010 |
| 72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99912686 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99713452 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99003635 |
| 75 | SA1_27219007_Chip-Seq_Bcells_Human | 0.97605337 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93721721 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92622277 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92519641 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92211813 |
| 80 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91437417 |
| 81 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.89719457 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89579446 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88815358 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87656368 |
| 85 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85690797 |
| 86 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.83806195 |
| 87 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83673872 |
| 88 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.83275783 |
| 89 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82560708 |
| 90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81600310 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80956305 |
| 92 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80938956 |
| 93 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.80514249 |
| 94 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.80469653 |
| 95 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.80380819 |
| 96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.79876272 |
| 97 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.79526346 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.79263873 |
| 99 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79003259 |
| 100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.78919763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.26637514 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.86528284 |
| 3 | MP0003724_increased_susceptibility_to | 3.63952621 |
| 4 | MP0003436_decreased_susceptibility_to | 3.42088674 |
| 5 | MP0009785_altered_susceptibility_to | 3.14366437 |
| 6 | MP0006082_CNS_inflammation | 3.14143919 |
| 7 | MP0003763_abnormal_thymus_physiology | 3.05865034 |
| 8 | MP0005025_abnormal_response_to | 2.94108815 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.90403760 |
| 10 | MP0001790_abnormal_immune_system | 2.84097076 |
| 11 | MP0005387_immune_system_phenotype | 2.84097076 |
| 12 | MP0001800_abnormal_humoral_immune | 2.81401738 |
| 13 | MP0000685_abnormal_immune_system | 2.76303852 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.68613149 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.55473872 |
| 16 | MP0002723_abnormal_immune_serum | 2.52804200 |
| 17 | MP0002419_abnormal_innate_immunity | 2.45897077 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.44336747 |
| 19 | MP0001819_abnormal_immune_cell | 2.42288926 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.39457937 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 2.33483680 |
| 22 | MP0003866_abnormal_defecation | 2.24703882 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.12561033 |
| 24 | MP0005360_urolithiasis | 2.11222088 |
| 25 | MP0001845_abnormal_inflammatory_respons | 1.98629442 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.98024760 |
| 27 | MP0004947_skin_inflammation | 1.96736131 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.88972741 |
| 29 | MP0003303_peritoneal_inflammation | 1.84563550 |
| 30 | MP0001873_stomach_inflammation | 1.82845516 |
| 31 | MP0000716_abnormal_immune_system | 1.82451525 |
| 32 | MP0002405_respiratory_system_inflammati | 1.78131425 |
| 33 | MP0002398_abnormal_bone_marrow | 1.73855286 |
| 34 | MP0008469_abnormal_protein_level | 1.64373845 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.58441008 |
| 36 | MP0005166_decreased_susceptibility_to | 1.56478669 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.55360187 |
| 38 | MP0002132_abnormal_respiratory_system | 1.49679552 |
| 39 | MP0002006_tumorigenesis | 1.48635558 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.48470020 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.43992608 |
| 42 | MP0000858_altered_metastatic_potential | 1.43328428 |
| 43 | MP0002722_abnormal_immune_system | 1.43282271 |
| 44 | MP0009764_decreased_sensitivity_to | 1.42725680 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.41581531 |
| 46 | MP0002429_abnormal_blood_cell | 1.39890229 |
| 47 | MP0002933_joint_inflammation | 1.36538221 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.35613100 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.34858390 |
| 50 | MP0009840_abnormal_foam_cell | 1.32172323 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.27958192 |
| 52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.26420726 |
| 53 | MP0003075_altered_response_to | 1.26081388 |
| 54 | MP0005085_abnormal_gallbladder_physiolo | 1.25787585 |
| 55 | MP0002139_abnormal_hepatobiliary_system | 1.24079928 |
| 56 | MP0005310_abnormal_salivary_gland | 1.23628364 |
| 57 | MP0003045_fibrosis | 1.20213635 |
| 58 | MP0003448_altered_tumor_morphology | 1.18773982 |
| 59 | MP0009763_increased_sensitivity_to | 1.10759071 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.07471106 |
| 61 | MP0001851_eye_inflammation | 1.06964924 |
| 62 | MP0005365_abnormal_bile_salt | 1.05343062 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.04713824 |
| 64 | MP0001853_heart_inflammation | 0.99632850 |
| 65 | MP0009643_abnormal_urine_homeostasis | 0.98150525 |
| 66 | MP0001765_abnormal_ion_homeostasis | 0.96183754 |
| 67 | MP0001663_abnormal_digestive_system | 0.95374659 |
| 68 | MP0005164_abnormal_response_to | 0.93883500 |
| 69 | MP0001666_abnormal_nutrient_absorption | 0.91724524 |
| 70 | MP0005083_abnormal_biliary_tract | 0.88398517 |
| 71 | MP0004019_abnormal_vitamin_homeostasis | 0.87893686 |
| 72 | MP0008260_abnormal_autophagy | 0.87025248 |
| 73 | MP0004883_abnormal_blood_vessel | 0.86944674 |
| 74 | MP0000604_amyloidosis | 0.85697512 |
| 75 | MP0002136_abnormal_kidney_physiology | 0.85427361 |
| 76 | MP0001986_abnormal_taste_sensitivity | 0.84067432 |
| 77 | MP0000490_abnormal_crypts_of | 0.82653998 |
| 78 | MP0000249_abnormal_blood_vessel | 0.82462135 |
| 79 | MP0005165_increased_susceptibility_to | 0.81442519 |
| 80 | MP0005390_skeleton_phenotype | 0.81279718 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.80173433 |
| 82 | MP0002396_abnormal_hematopoietic_system | 0.75838220 |
| 83 | MP0003252_abnormal_bile_duct | 0.75774372 |
| 84 | MP0000343_altered_response_to | 0.74350016 |
| 85 | MP0004510_myositis | 0.72191323 |
| 86 | MP0004264_abnormal_extraembryonic_tissu | 0.70363982 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.68609847 |
| 88 | MP0010329_abnormal_lipoprotein_level | 0.68186187 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67535331 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.66044929 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.65980230 |
| 92 | MP0003690_abnormal_glial_cell | 0.65133253 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.64644744 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 0.64528391 |
| 95 | MP0004381_abnormal_hair_follicle | 0.63870099 |
| 96 | MP0008004_abnormal_stomach_pH | 0.62514442 |
| 97 | MP0008874_decreased_physiological_sensi | 0.62278518 |
| 98 | MP0003795_abnormal_bone_structure | 0.61582563 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.61071878 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.60976838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.44444841 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.64213174 |
| 3 | Myositis (HP:0100614) | 4.32280633 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.30341947 |
| 5 | T lymphocytopenia (HP:0005403) | 4.14796748 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.03327232 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.91121979 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.88867544 |
| 9 | Autoimmune hemolytic anemia (HP:0001890) | 3.83037899 |
| 10 | Increased IgM level (HP:0003496) | 3.81149939 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.71157147 |
| 12 | Nasal polyposis (HP:0100582) | 3.60740921 |
| 13 | Orchitis (HP:0100796) | 3.60530166 |
| 14 | Encephalitis (HP:0002383) | 3.49716035 |
| 15 | Abnormality of T cells (HP:0002843) | 3.48739351 |
| 16 | Recurrent bronchitis (HP:0002837) | 3.44027612 |
| 17 | Stomatitis (HP:0010280) | 3.40578519 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.39949636 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.37901247 |
| 20 | Optic neuritis (HP:0100653) | 3.37901247 |
| 21 | Meningitis (HP:0001287) | 3.32164982 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.27075235 |
| 23 | Chronic diarrhea (HP:0002028) | 3.26627012 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 3.22696039 |
| 25 | Vasculitis (HP:0002633) | 3.22043066 |
| 26 | Pustule (HP:0200039) | 3.19549646 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.18362532 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 3.18160072 |
| 29 | IgG deficiency (HP:0004315) | 3.13963145 |
| 30 | Hypergammaglobulinemia (HP:0010702) | 2.95796104 |
| 31 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.95166461 |
| 32 | Chronic otitis media (HP:0000389) | 2.93185549 |
| 33 | Eosinophilia (HP:0001880) | 2.92724235 |
| 34 | Obstructive lung disease (HP:0006536) | 2.91861711 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91861711 |
| 36 | Granulocytopenia (HP:0001913) | 2.91218510 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91030417 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91030417 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.89409613 |
| 40 | Leukocytosis (HP:0001974) | 2.89011787 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.88702515 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 2.85847892 |
| 43 | Recurrent skin infections (HP:0001581) | 2.85711765 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.85205945 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.84164997 |
| 46 | Bronchiectasis (HP:0002110) | 2.83915834 |
| 47 | Bronchitis (HP:0012387) | 2.82243277 |
| 48 | Abnormality of eosinophils (HP:0001879) | 2.79773596 |
| 49 | Panhypogammaglobulinemia (HP:0003139) | 2.74737172 |
| 50 | Severe combined immunodeficiency (HP:0004430) | 2.73689269 |
| 51 | Agammaglobulinemia (HP:0004432) | 2.72669457 |
| 52 | Increased IgE level (HP:0003212) | 2.70053246 |
| 53 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.69456781 |
| 54 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.69456781 |
| 55 | Purpura (HP:0000979) | 2.68257974 |
| 56 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.67589571 |
| 57 | Absent/shortened dynein arms (HP:0200106) | 2.67589571 |
| 58 | Recurrent sinusitis (HP:0011108) | 2.66130577 |
| 59 | Malnutrition (HP:0004395) | 2.60735598 |
| 60 | Chronic sinusitis (HP:0011109) | 2.60571095 |
| 61 | Recurrent viral infections (HP:0004429) | 2.59425508 |
| 62 | Petechiae (HP:0000967) | 2.57361233 |
| 63 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.56768429 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.55878991 |
| 65 | Hemoptysis (HP:0002105) | 2.51716479 |
| 66 | Abnormal ciliary motility (HP:0012262) | 2.50523353 |
| 67 | Urticaria (HP:0001025) | 2.48537177 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.47312102 |
| 69 | Joint swelling (HP:0001386) | 2.40589711 |
| 70 | Chest pain (HP:0100749) | 2.40038555 |
| 71 | Gastrointestinal inflammation (HP:0004386) | 2.39701267 |
| 72 | IgM deficiency (HP:0002850) | 2.38657251 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.37791575 |
| 74 | Pulmonary embolism (HP:0002204) | 2.37134791 |
| 75 | Keratoconjunctivitis (HP:0001096) | 2.35604893 |
| 76 | Gingivitis (HP:0000230) | 2.35597532 |
| 77 | Lymphopenia (HP:0001888) | 2.32203002 |
| 78 | Epistaxis (HP:0000421) | 2.29398363 |
| 79 | Rhinitis (HP:0012384) | 2.26722871 |
| 80 | Gingival bleeding (HP:0000225) | 2.25243550 |
| 81 | Prolonged bleeding time (HP:0003010) | 2.24502676 |
| 82 | Colitis (HP:0002583) | 2.24484974 |
| 83 | Recurrent otitis media (HP:0000403) | 2.22337513 |
| 84 | Abnormality of B cell number (HP:0010975) | 2.22101175 |
| 85 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.21398229 |
| 86 | Hypoproteinemia (HP:0003075) | 2.19914344 |
| 87 | Anorexia (HP:0002039) | 2.17134764 |
| 88 | Skin rash (HP:0000988) | 2.09488475 |
| 89 | Combined immunodeficiency (HP:0005387) | 2.09253127 |
| 90 | Gangrene (HP:0100758) | 2.08176879 |
| 91 | Alveolar cell carcinoma (HP:0006519) | 2.07685572 |
| 92 | Hypochromic anemia (HP:0001931) | 2.06854961 |
| 93 | Arterial thrombosis (HP:0004420) | 2.01240233 |
| 94 | Abnormality of the pleura (HP:0002103) | 1.99227905 |
| 95 | Thyroiditis (HP:0100646) | 1.98053385 |
| 96 | Increased serum ferritin (HP:0003281) | 1.97230968 |
| 97 | Chronic bronchitis (HP:0004469) | 1.92375154 |
| 98 | Abnormality of the prostate (HP:0008775) | 1.92059124 |
| 99 | Acute hepatic failure (HP:0006554) | 1.90045369 |
| 100 | Complement deficiency (HP:0004431) | 1.89463419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.13836434 |
| 2 | TXK | 3.99158313 |
| 3 | TESK2 | 2.97584858 |
| 4 | RIPK4 | 2.69658026 |
| 5 | ERN1 | 2.69598040 |
| 6 | TYK2 | 2.59975850 |
| 7 | GRK6 | 2.56522627 |
| 8 | TAOK3 | 2.53801949 |
| 9 | KDR | 2.51931786 |
| 10 | ZAP70 | 2.50820800 |
| 11 | FES | 2.37848634 |
| 12 | CSK | 2.20726569 |
| 13 | IKBKE | 2.15719249 |
| 14 | TBK1 | 2.10307570 |
| 15 | TNK2 | 2.01518761 |
| 16 | JAK3 | 1.91373519 |
| 17 | ITK | 1.85362888 |
| 18 | BTK | 1.84789037 |
| 19 | JAK1 | 1.82118366 |
| 20 | IRAK4 | 1.78205835 |
| 21 | SYK | 1.71816381 |
| 22 | EPHB1 | 1.71696691 |
| 23 | BLK | 1.69769746 |
| 24 | MAP3K3 | 1.63469172 |
| 25 | MAP3K11 | 1.57853740 |
| 26 | KIT | 1.53013158 |
| 27 | LCK | 1.49098074 |
| 28 | TLK1 | 1.45979916 |
| 29 | MST4 | 1.44244946 |
| 30 | TESK1 | 1.43323469 |
| 31 | STK10 | 1.38212259 |
| 32 | MAP3K14 | 1.33079985 |
| 33 | MAP2K3 | 1.32910868 |
| 34 | IKBKB | 1.31040244 |
| 35 | LYN | 1.26802835 |
| 36 | CSF1R | 1.26067120 |
| 37 | MARK3 | 1.25265729 |
| 38 | TEC | 1.24984078 |
| 39 | HCK | 1.22166813 |
| 40 | FGFR4 | 1.17603939 |
| 41 | MST1R | 1.12381614 |
| 42 | PRKCQ | 1.11583502 |
| 43 | BMPR2 | 1.10697854 |
| 44 | EPHA2 | 1.06815456 |
| 45 | EPHA3 | 1.03758810 |
| 46 | GRK7 | 1.00247273 |
| 47 | MAPK15 | 0.95869156 |
| 48 | JAK2 | 0.86461661 |
| 49 | MAP3K12 | 0.85417843 |
| 50 | NLK | 0.79425824 |
| 51 | MAP2K6 | 0.79003119 |
| 52 | PIM1 | 0.78794821 |
| 53 | MAP3K13 | 0.78035897 |
| 54 | PRPF4B | 0.77431282 |
| 55 | LRRK2 | 0.75318721 |
| 56 | HIPK2 | 0.75015287 |
| 57 | FGFR3 | 0.74219401 |
| 58 | ACVR1B | 0.73926343 |
| 59 | MAP3K1 | 0.73374857 |
| 60 | SIK3 | 0.72736389 |
| 61 | FGR | 0.68338918 |
| 62 | ADRBK2 | 0.68327517 |
| 63 | CAMKK2 | 0.64297095 |
| 64 | PTK2B | 0.64254395 |
| 65 | FYN | 0.63164621 |
| 66 | MATK | 0.61179608 |
| 67 | MAP2K2 | 0.59482768 |
| 68 | TGFBR2 | 0.58055859 |
| 69 | PIK3CG | 0.57316635 |
| 70 | PTK6 | 0.56123622 |
| 71 | MAP3K2 | 0.55963451 |
| 72 | PDK1 | 0.54373571 |
| 73 | PIK3CA | 0.52471633 |
| 74 | PRKG2 | 0.52346658 |
| 75 | IRAK1 | 0.52158844 |
| 76 | MYLK | 0.51899882 |
| 77 | TAOK1 | 0.49227331 |
| 78 | BCKDK | 0.48907915 |
| 79 | MAPK11 | 0.48720486 |
| 80 | TAOK2 | 0.45152305 |
| 81 | MAPKAPK3 | 0.44346902 |
| 82 | RIPK1 | 0.43047265 |
| 83 | PRKCD | 0.42668453 |
| 84 | GRK5 | 0.42127337 |
| 85 | MAPKAPK2 | 0.41974558 |
| 86 | IGF1R | 0.39328557 |
| 87 | CDK19 | 0.37651703 |
| 88 | MAPK7 | 0.35864602 |
| 89 | CAMKK1 | 0.35818961 |
| 90 | CDC42BPA | 0.35040264 |
| 91 | ABL1 | 0.32984997 |
| 92 | SCYL2 | 0.32963730 |
| 93 | PDPK1 | 0.32078544 |
| 94 | DAPK1 | 0.30566760 |
| 95 | TRPM7 | 0.29881368 |
| 96 | LIMK1 | 0.27809774 |
| 97 | SRC | 0.27249989 |
| 98 | MAP3K5 | 0.26720128 |
| 99 | INSR | 0.25309392 |
| 100 | LMTK2 | 0.24634878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.03222342 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.83860622 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.71838854 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.66693187 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.00855505 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.90992271 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.67554924 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.67249088 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.61956263 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37220843 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.32269667 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.30738699 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.10767417 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.96373547 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.73534833 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.65634728 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.60724311 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59991623 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.56399355 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49505217 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42634339 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37902948 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32943172 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31952055 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27293825 |
| 26 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.26544538 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26308263 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.26308078 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23843567 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.21481789 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.20207081 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15465238 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.13737396 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13174783 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12008914 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.11978082 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10179594 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08379440 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08254481 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07957525 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04157886 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03574369 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02604867 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 0.99264614 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95298694 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93441386 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92284759 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.86334985 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.86274364 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83231517 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 0.82320825 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82284413 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.80816341 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.80434504 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.79680176 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78948490 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.78425353 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.71311060 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69955499 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.64257565 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61939696 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61769002 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58791413 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57790043 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57779146 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56657281 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.55824606 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55639743 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.54018688 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49244431 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48086968 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.47939962 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44960779 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43416579 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42495791 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39390384 |
| 77 | Proteasome_Homo sapiens_hsa03050 | 0.39242758 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37381013 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.36534510 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36320825 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36189001 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36124768 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35730341 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35663669 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.34376158 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.33111513 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32207736 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32128185 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.31794780 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.31295933 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30506570 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29680230 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29574725 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28651323 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28276405 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26981891 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24165765 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24089193 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23709013 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23065899 |

